Recruiting

rTMS

Sponsor:

University of Calgary

Code:

NCT04532190

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Not accepted

Interventions

rTMS

Study Details

Brief summary:

Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Study ID

NCT04532190

Start date

Mar 1, 2026

Status verified date

May, 2026

Completion date

Dec 31, 2027

Anticipated

Primary completion date

Dec 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Diagnosis of ADHD
2. 9-15 years old
3. IQ greater than 80
4. English fluency (to enable consent/assent)
5. If on medication, must have been on the same type and dosage for at least 3 months.

Exclusion Criteria:

1. Diagnosis of mania, psychosis, or bipolar disorder
2. Impediments to TMS or MRI (i.e. metal implants in body)
3. Prior electroconvulsive therapy or vagus nerve stimulation
4. Diagnosis of Autism Spectrum Disorder.

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Active rTMS

Active repetitive TMS

Interventions

rTMS

Repetitive transcranial magnetic stimulation (rTMS)

Primary outcome measure

  • TEACH-2 [ Time Frame: Baseline to week 5 ]

Central Contacts and Locations

Locations

Alberta Children's Hospital

Recruiting

Calgary, Alberta, Canada, T3B 6A8

Contacts

Kara r Murias, MD/PhD

1 403-441-8411krmarten@ucalgary.ca

Kara Murias

brainkids@ucalgary.ca

More Information

Sponsor

University of Calgary

Last update posted

May 14, 2026

Last verified

May, 2026

Keywords

  • Attention-Deficit/Hyperactivity Disorder (ADHD
  • Repetitive transcranial magnetic stimulation (rTMS)

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Calgary on 2026-05-14.